Academia
Tennessee’s innovative clinical trials network is soaring just one year into operations, bringing growing benefits for Tennesseans and the advancement of health care across the state.
Construction to host IBA’s Proteus®ONE system expected to start later this year
There is, thankfully, no age limit on innovation—you can do it at any age. But for many, “young,” counts as under 30, sometimes under 35, or even under 40, at least in terms of putting together lists of scientific innovators.
Second clinical trial of Pill Connect system to be undertaken through University of Groningen following successful trial of prototypes with major CRO
Eisai Co.,Ltd. has entered into a collaboration research agreement with the University of Dundee in Scotland, UK, regarding Proteolysis Targeting Chimeras (PROTACs)(1) toward drug discovery in oncology area.
“Non-muscle invasive bladder cancer is a highly prevalent illness that requires an intrusive and often lengthy treatment plan,” stated Hardev Pandha, lead investigator and Professor of Medical Oncology at the University of Surrey, reported Forbes. “Current treatment is ineffective and toxic in a proportion of patients and there is an urgent need for new therapies.”
Anahit International Corp. has licensed a patent from the University of Guelph to biosynthesize Cannflavin A and B outside of the cannabis plant.
Innovative technology developed by researchers at the Technion and Kahn-Sagol-Maccabi Research and Innovation Institute at Maccabi Healthcare Services is expected to improve and make more efficient the giving of antibiotic treatments.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
According to a University College London (UCL) report, British researchers are being shut out of major European research partnerships because of concerns over a no-deal Brexit.
PRESS RELEASES